General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.24.4
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Pieris Pharmaceuticals, Inc. [Member]
Preferred Stock [Member]
Pieris Pharmaceuticals, Inc. [Member]
Common Stock [Member]
Pieris Pharmaceuticals, Inc. [Member]
Additional Paid-in Capital [Member]
Pieris Pharmaceuticals, Inc. [Member]
AOCI Attributable to Parent [Member]
Pieris Pharmaceuticals, Inc. [Member]
Retained Earnings [Member]
Pieris Pharmaceuticals, Inc. [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2021 16,000 903,000         13,525,560 5,708,030      
Balance at Dec. 31, 2021 $ 0 $ 1 $ 307,069 $ 829 $ (257,144) $ 50,755 $ 61,071 $ 0 $ 754 $ (67,440) $ (66,686)
Net loss 0 0 0 0 (33,277) (33,277) 0 0 0 (27,552) (27,552)
Stock based compensation expense 0 0 4,402 0 0 4,402 $ 0 $ 0 427 0 427
Foreign currency translation adjustment 0 0 0 (1,010) 0 (1,010)          
Unrealized gain on investments $ 0 $ 0 0 (73) 0 $ (73)          
Issuance of common stock resulting from purchase of employee stock purchase plan shares (in shares) 0 2,000       2,268          
Issuance of common stock resulting from purchase of employee stock purchase plan shares $ 0 $ 0 197 0 0 $ 197          
Issuance of common stock pursuant to ATM offering program, net of $0.7 million in offering costs (in shares) 0 25,000                  
Issuance of common stock pursuant to ATM offering program, net of $0.7 million in offering costs $ 0 $ 0 6,840 0 0 6,840          
Unrealized gain on investments $ 0 $ 0 0 (73) 0 (73)          
Balance (in shares) at Dec. 31, 2022 16,000 931,000         15,360,787 5,720,009      
Balance at Dec. 31, 2022 $ 0 $ 1 318,603 (254) (290,421) 27,929 $ 70,603 $ 0 1,215 (94,992) (93,777)
Net loss 0 0 0 0 (19,959) (19,959) 0 0 0 (1,848) (1,848)
Stock based compensation expense 0 0 2,898 0 0 2,898 $ 0 $ 0 454 0 454
Foreign currency translation adjustment 0 0 0 (159) 0 (159)          
Unrealized gain on investments $ 0 $ 0 0 74 0 74          
Issuance of common stock resulting from purchase of employee stock purchase plan shares (in shares) 0 1,000                  
Issuance of common stock resulting from purchase of employee stock purchase plan shares $ 0 $ 0 52 0 0 52          
Issuance of common stock pursuant to ATM offering program, net of $0.7 million in offering costs (in shares) 0 303,000                  
Issuance of common stock pursuant to ATM offering program, net of $0.7 million in offering costs $ 0 $ 0 19,675 0 0 19,675          
Unrealized gain on investments $ 0 $ 0 0 74 0 74          
Balance (in shares) at Sep. 30, 2023 16,000 1,236,000         15,360,787 5,720,009      
Balance at Sep. 30, 2023 $ 0 $ 1 341,228 (339) (310,380) 30,510 $ 70,603 $ 0 1,669 (96,840) (95,171)
Balance (in shares) at Dec. 31, 2022 16,000 931,000         15,360,787 5,720,009      
Balance at Dec. 31, 2022 $ 0 $ 1 318,603 (254) (290,421) 27,929 $ 70,603 $ 0 1,215 (94,992) (93,777)
Net loss 0 0 0 0 (24,543) (24,543) 0 0 0 18,691 18,691
Stock based compensation expense 0 0 3,349 0 0 3,349 $ 0 $ 0 603 0 603
Foreign currency translation adjustment 0 0 0 208 0 208          
Unrealized gain on investments $ 0 $ 0 0 74 0 $ 74          
Issuance of common stock resulting from purchase of employee stock purchase plan shares (in shares) 0 2,000       1,933          
Issuance of common stock resulting from purchase of employee stock purchase plan shares $ 0 $ 0 66 0 0 $ 66          
Issuance of common stock pursuant to ATM offering program, net of $0.7 million in offering costs (in shares) 0 304,000                  
Issuance of common stock pursuant to ATM offering program, net of $0.7 million in offering costs $ 0 $ 0 19,675 0 0 19,675          
Unrealized gain on investments $ 0 $ 0 0 74 0 74          
Balance (in shares) at Dec. 31, 2023 16,000 1,237,000         15,360,787 5,720,009      
Balance at Dec. 31, 2023 $ 0 $ 1 341,693 28 (314,964) 26,758 $ 70,603 $ 0 1,818 (76,301) (74,483)
Balance (in shares) at Jun. 30, 2023 16,000 1,236,000         15,360,787 5,720,009      
Balance at Jun. 30, 2023 $ 0 $ 1 340,262 (137) (299,628) 40,498 $ 70,603 $ 0 1,515 (94,008) (92,493)
Net loss 0 0 0 0 (10,752) (10,752) 0 0 0 (2,832) (2,832)
Stock based compensation expense 0 0 966 0 0 966 $ 0 $ 0 154 0 154
Foreign currency translation adjustment 0 0 0 (204) 0 (204)          
Unrealized gain on investments 0 0 0 2 0 2          
Unrealized gain on investments $ 0 $ 0 0 2 0 2          
Balance (in shares) at Sep. 30, 2023 16,000 1,236,000         15,360,787 5,720,009      
Balance at Sep. 30, 2023 $ 0 $ 1 341,228 (339) (310,380) 30,510 $ 70,603 $ 0 1,669 (96,840) (95,171)
Balance (in shares) at Dec. 31, 2023 16,000 1,237,000         15,360,787 5,720,009      
Balance at Dec. 31, 2023 $ 0 $ 1 341,693 28 (314,964) 26,758 $ 70,603 $ 0 1,818 (76,301) (74,483)
Net loss 0 0 0 0 (11,369) (11,369) 0 0 0 (13,483) (13,483)
Stock based compensation expense 0 0 1,223 0 0 1,223 $ 0 $ 0 562 0 562
Foreign currency translation adjustment 0 0 0 (343) 0 (343)          
Unrealized gain on investments 0 0 0 (1) 0 (1)          
Unrealized gain on investments $ 0 $ 0 0 (1) 0 (1)          
Round-Up shares from the 1-for-80 reverse split effective April 23, 2024 (in shares) 0 83,000                  
Balance (in shares) at Sep. 30, 2024 16,000 1,320,000         15,360,787 5,720,009      
Balance at Sep. 30, 2024 $ 0 $ 1 342,916 (316) (326,333) 16,268 $ 70,603 $ 0 2,380 (89,784) (87,404)
Balance (in shares) at Jun. 30, 2024 16,000 1,320,000         15,360,787 5,720,009      
Balance at Jun. 30, 2024 $ 0 $ 1 342,586 (436) (323,446) 18,705 $ 70,603 $ 0 2,181 (83,009) (80,828)
Net loss 0 0 0 0 (2,887) (2,887) 0 0 0 (6,775) (6,775)
Stock based compensation expense 0 0 330 0 0 330 $ 0 $ 0 199 0 199
Foreign currency translation adjustment $ 0 $ 0 0 120 0 120          
Balance (in shares) at Sep. 30, 2024 16,000 1,320,000         15,360,787 5,720,009      
Balance at Sep. 30, 2024 $ 0 $ 1 $ 342,916 $ (316) $ (326,333) $ 16,268 $ 70,603 $ 0 $ 2,380 $ (89,784) $ (87,404)